After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
INMB belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of INmune Bio Inc is $103.54M. A total of 0.21 million shares were traded on the day, compared to an average of 220.50K shares.
In the most recent transaction, Moss David J bought 10,000 shares of INMB for 5.29 per share on Sep 30 ’24. After the transaction, the Chief Financial Officer now owns 1,285,869 company shares. In a previous transaction on Sep 12 ’24, Tesi Raymond Joseph bought 15,380 shares at 6.38 per share. INMB shares that President and CEO owns now total 1,554,106.
Among the insiders who bought shares, Moss David J acquired of 7,690 shares on Sep 12 ’24 at a per-share price of $6.38. This resulted in the Chief Financial Officer holding 1,275,869 shares of INMB after the transaction. In another insider transaction, Juda Scott bought 5,000 shares at $7.27 per share on Jun 25 ’24. Company shares held by the Director now total 71,603.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, INMB has a high of $14.74 and a low of $4.32.
As of this writing, INMB has an earnings estimate of -$0.56 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.45 per share and a lower estimate of -$0.66.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. INMB’s latest balance sheet shows that the firm has $74.81M in Cash & Short Term Investments as of fiscal 2021. There were $15.23M in debt and $4.36M in liabilities at the time. Its Book Value Per Share was $1.74, while its Total Shareholder’s Equity was $80.22M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INMB is Buy with a score of 4.80.
